42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-602066
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 371ccff2-1271-4859-8eb8-117d2064c0e4
[Document ID] => 602066
[Document naam] => Evaluation of NOVAVAX NVX.docx
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3294932-1021608-wjz/document/VWS-WOO-08-602066
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-602066
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3294932-1021608-wjz
[DocumentPublicationDate] => 24 augustus 2020
[DocumentStatusCheckedDate] => 2026-04-27 22:33:06.771046
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 02:04:01
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 02:04:01
)
Document: VWS-WOO-08-602066
Klik om te vergroten
Document correcties
Geregistreerde datum: 20200824
Geregistreerde documentnaam: Evaluation of NOVAVAX NVX.docx
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang publicatie | 3.746 documenten waarvan 2.222 openbaar gemaakt Inventarislijst | 2026-03-11 02:25:05 |
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2026-03-11 02:25:05 |
| Request_Omvang publicatie_paginas | 3.746 | 2026-03-11 02:25:05 |
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3294932-1021608-wjz/file/download/inventory | 2026-03-11 02:25:05 |
| document_SectionDownloadButton | 1 | 2025-09-01 11:21:15 |
| About_Gelakte gegevens | Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-01 11:21:15 |
| About_Gelakte gegevens_linkhref_1 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-01 11:21:15 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-30 04:00:13 |
| document_documentName | Evaluation of NOVAVAX NVX.docx | 2025-06-30 04:00:13 |
| document_documentType | Word-document | 2025-06-30 04:00:13 |
| document_documentPublicationDate | 2020-08-24 | 2025-06-30 04:00:13 |
| document_documentNumber | VWS-WOO-08-602066 | 2025-06-30 04:00:13 |
| document_SectionHTMLDataDivs | 2 | 2025-06-30 04:00:13 |
| document_SectionAbout | 1 | 2025-06-30 04:00:13 |
| About_Datum document | 24 augustus 2020 | 2025-06-30 04:00:13 |
| document_SectionDownloadButton | 0 | 2025-06-30 04:00:13 |
| About_Type bronbestand_paginas | 2 | 2025-06-30 04:00:13 |
| About_Download als | PDF (842 KB) | 2025-06-30 04:00:13 |
| About_Documentnummer | 602066 | 2025-06-30 04:00:13 |
| About_Beoordeling | Openbaarmaking | 2025-06-30 04:00:13 |
| About_Gelakte gegevens_linkname_1 | Laat het ons weten | 2025-06-30 04:00:13 |
| document_SectionRequest | 1 | 2025-06-30 04:00:13 |
| Request_Onderdeel van | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode augustus 2020 | 2025-06-30 04:00:13 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3294932-1021608-wjz | 2025-06-30 04:00:13 |
| Request_Onderdeel van_linkname_1 | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode augustus 2020 | 2025-06-30 04:00:13 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 23 december 2021 een besluit genomen op verzoeken in het kader van de Wet openbaarheid van bestuur. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en medicatie over de periode augustus 2020. | 2025-06-30 04:00:13 |
| Request_Periode | Augustus 2020 | 2025-06-30 04:00:13 |
| Request_Type besluit | Wob-besluit | 2025-06-30 04:00:13 |
| Request_Datum besluit | 23 december 2021 | 2025-06-30 04:00:13 |
| About_Type bronbestand | Word-document, 2 pagina's | 2025-06-30 04:00:13 |
| About_Gelakte gegevens | Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-30 04:00:13 |
| About_Gelakte gegevens_linkhref_1 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Evaluation of NOVAVAX NVX.docx (documentnummer 1eff8f07-8394-6b82-a430-dfe01757c6c9) | 2025-06-30 04:00:13 |
| Request_Omvang openbaarmaking | 3.740 documenten, 4.587 pagina's Inventarislijst | 2025-06-30 04:00:13 |
| Request_Omvang openbaarmaking_documenten | 3.740 | 2025-06-30 04:00:13 |
| Request_Omvang openbaarmaking_paginas | 4.587 | 2025-06-30 04:00:13 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3294932-1021608-wjz/file/download/inventory | 2025-06-30 04:00:13 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-602066.pdf | 2025-04-19 11:21:48 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3294932-1021608-wjz/file/download/document/1eff8f07-8394-6b82-a430-dfe01757c6c9 | 2025-04-19 11:21:48 |
| DocumentDownload_linkname | Download (pdf, 842 KB) | 2025-04-19 11:21:48 |
Archiefversies (6 rijen)
Archiefrij 1 — 2025-11-21 14:49:13
fromFile: VWS-WOO-3294932-1021608-wjz-1f0a50ba-31ed-6336-829a-3b248d46981f.zip
fromFilePath: archieven_files\VWS-WOO-3294932-1021608-wjz-1f0a50ba-31ed-6336-829a-3b248d46981f.zip
documentName: VWS-WOO-08-602066.pdf
documentType: pdf
documentCompressedSize: 588732
documentSize: 862203
documentCompressRatio: 68.28229546870053
documentDateModified: 2025-10-09 12:31:20
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 14:49:13
lastSeen: 2025-11-21 14:49:13
text: 602066
Evaluation of NOVAVAX NVX CoV2373 vaccine
1
Description of the vaccine
The vaccine consists of trimers of the full length spike protein
including the
transmembrane domain stabilized in the prefusion state The trimers were
formulated in 0 01
polysorbate 80 leading to nanoparticles that c...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 24cb8b2a509c2aefb473764bb22c7239dbfd567063bbce3aac442a2826dc7eb1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: d0c3f8d8-29b8-41c7-b5e9-09fc7df773a9
textDigestSHA256: a4cc48f813661be1ed654dbff7fee228ae16bdf2797495547087dd72be93aa98
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-602066
Archiefrij 2 — 2025-11-21 14:48:04
fromFile: VWS-WOO-3294932-1021608-wjz-1f02ffc4-f046-6d8a-8003-7faf822cdfa9.zip
fromFilePath: archieven_files\VWS-WOO-3294932-1021608-wjz-1f02ffc4-f046-6d8a-8003-7faf822cdfa9.zip
documentName: VWS-WOO-08-602066.pdf
documentType: pdf
documentCompressedSize: 588732
documentSize: 862203
documentCompressRatio: 68.28229546870053
documentDateModified: 2025-10-09 12:31:20
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 14:48:04
lastSeen: 2025-11-21 14:48:04
text: 602066
Evaluation of NOVAVAX NVX CoV2373 vaccine
1
Description of the vaccine
The vaccine consists of trimers of the full length spike protein
including the
transmembrane domain stabilized in the prefusion state The trimers were
formulated in 0 01
polysorbate 80 leading to nanoparticles that c...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 24cb8b2a509c2aefb473764bb22c7239dbfd567063bbce3aac442a2826dc7eb1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: a39f8389-de1e-45c4-b581-3a4c1e638ae7
textDigestSHA256: a4cc48f813661be1ed654dbff7fee228ae16bdf2797495547087dd72be93aa98
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-602066
Archiefrij 3 — 2025-09-08 18:25:32
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-602066.pdf
documentName: VWS-WOO-08-602066.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 862203
documentCompressRatio: 0
documentDateModified: 2025-09-08 18:25:32
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-08 18:25:32
lastSeen: 2025-09-08 18:25:32
text: 602066
Evaluation ofNOVAVAX NVX CoV2373 vaccine
1Descriptionofthe vaccine
The vaccine consists oftrimers ofthe fulllength spike protein includingthe
transmembrane domain stabilized intheprefusion state The trimers were
formulated in001 polysorbate 80leading tonanoparticles that contain multi
trimer ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 24cb8b2a509c2aefb473764bb22c7239dbfd567063bbce3aac442a2826dc7eb1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_30054_a077302df4df1a994c81eb702499f100
textDigestSHA256: 260b9d040eb6316e4024f7aedabb41962beb73b931bee8680a05a00745d8095d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-602066
Archiefrij 4 — 2025-09-04 16:16:49
fromFile: VWS-WOO-3294932-1021608-wjz-1f02ffc4-f046-6d8a-8003-7faf822cdfa9.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3294932-1021608-wjz-1f02ffc4-f046-6d8a-8003-7faf822cdfa9.1.zip
documentName: VWS-WOO-08-602066.pdf
documentType: pdf
documentCompressedSize: 588732
documentSize: 862203
documentCompressRatio: 68.28229546870053
documentDateModified: 2025-05-13 13:16:40
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:16:49
lastSeen: 2025-11-21 13:47:41
text: 602066
Evaluation ofNOVAVAX NVX CoV2373 vaccine
1Descriptionofthe vaccine
The vaccine consists oftrimers ofthe fulllength spike protein includingthe
transmembrane domain stabilized intheprefusion state The trimers were
formulated in001 polysorbate 80leading tonanoparticles that contain multi
trimer ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 24cb8b2a509c2aefb473764bb22c7239dbfd567063bbce3aac442a2826dc7eb1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3294932-1021608-wjz-1f02ffc4-f046-6d8a-8003-7faf822cdfa9.zip_782
textDigestSHA256: 260b9d040eb6316e4024f7aedabb41962beb73b931bee8680a05a00745d8095d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-602066
Archiefrij 5 — 2025-03-18 09:30:24
fromFile: 2021.109-VWS-WOO-3294932-1021608-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2021.109-VWS-WOO-3294932-1021608-wjz.zip
documentName: VWS-WOO-08-602066.pdf
documentType: pdf
documentCompressedSize: 587803
documentSize: 862203
documentCompressRatio: 68.17454822124256
documentDateModified: 2025-03-04 14:02:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:24
lastSeen: 2025-03-18 09:30:24
text: 602066
Evaluation ofNOVAVAX NVX CoV2373 vaccine
1Descriptionofthe vaccine
The vaccine consists oftrimers ofthe fulllength spike protein includingthe
transmembrane domain stabilized intheprefusion state The trimers were
formulated in001 polysorbate 80leading tonanoparticles that contain multi
trimer ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 260b9d040eb6316e4024f7aedabb41962beb73b931bee8680a05a00745d8095d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: 307339
textDigestSHA256: 260b9d040eb6316e4024f7aedabb41962beb73b931bee8680a05a00745d8095d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-602066
Archiefrij 6 — 2025-03-05 15:58:47
fromFile: VWS-WOO-3294932-1021608-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3294932-1021608-wjz.zip
documentName: VWS-WOO-08-602066.pdf
documentType: pdf
documentCompressedSize: 587803
documentSize: 862203
documentCompressRatio: 68.17454822124256
documentDateModified: 2025-03-04 14:02:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-05 15:58:47
lastSeen: 2025-03-05 15:58:47
text: 602066
Evaluation ofNOVAVAX NVX CoV2373 vaccine
1Descriptionofthe vaccine
The vaccine consists oftrimers ofthe fulllength spike protein includingthe
transmembrane domain stabilized intheprefusion state The trimers were
formulated in001 polysorbate 80leading tonanoparticles that contain multi
trimer ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 260b9d040eb6316e4024f7aedabb41962beb73b931bee8680a05a00745d8095d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 300271
textDigestSHA256: 260b9d040eb6316e4024f7aedabb41962beb73b931bee8680a05a00745d8095d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-602066
(dit is ook een speeltuin)